FPT Software and E.ON Strengthen Partnership, Eyeing Offshore Delivery Opportunity
23.8.2023 10:00:00 EEST | Business Wire | Press release
FPT Software announced the partnership with E.ON, one of Europe’s major energy companies. The two sides look to take their collaboration to a more comprehensive level by considering future opportunities of opening a delivery center in Vietnam.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230823357599/en/
Leaders of FPT Software and E.ON at FPT Software’s campus in Hanoi, Vietnam (Photo: Business Wire)
In light of Vietnam’s potential as an emerging digital nation and the existing partnership with FPT Software, E.ON shows consideration for opening an offshore development center (ODC) in Vietnam in such fields as SAP, DevOps, Data Analytics, AI. The future ODC is expected to help E.ON diversify its delivery locations to ensure business resilience and agility. In response to this opportunity, FPT Software plans to leverage its best-shore delivery model through an extensive network across Europe and Asia to provide E.ON with round-the-clock support, cost-effectiveness and workforce scalability.
This collaboration prospect was considered during E.ON’s recent trip to Vietnam, where E.ON leaders visited FPT Software’s campuses and FPT University to understand more about FPT Software’s facilities and education for next-generation IT professionals.
Both companies also share a common vision for diversity, equity and inclusion in the workplace. Particularly, E.ON’s Chief Operating Officer and Board Member Victoria Ossadnik and FPT Software Chairwoman Chu Thi Thanh Ha participated in a talk titled “Women in Tech: Break through the Barriers” to discuss women’s role in IT organizations and career advancement opportunities for female employees.
“We are excited to strengthen our partnership with E.ON. Our joint efforts in sustainability development and shared vision in digital transformation will surely bring greater values to both companies,” said FPT Software Europe’s Chief Executive Officer Le Hai.
E.ON’s Chief Operating Officer Victoria Ossadnik expressed satisfaction with the trip’s outcomes. “It would be a big mistake for E.ON not to visit Vietnam,” she said.
During their five-year collaboration, FPT Software and E.ON have joined forces in several projects in SAP, ServiceNow, Sitecore, DevOps, Application Development, Testing and Cloud. Of note was a project involving SAP authorizations for over 60.000 end-users across Europe. FPT Software also supported E.ON One, the energy transition digital solution provider under E.ON, in their sustainable energy consumption project.
About FPT Software
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $803 million in revenue (2022) and over 27,000 employees in 28 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,000+ clients worldwide, 89 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230823357599/en/
Contact information
Mai Duong (Ms.)
FPT Software
PR Manager
MCP.PR@fpt.com
https://www.fptsoftware.com/newsroom/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom